Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.120
-0.050 (-4.27%)
Jul 16, 2026, 4:00 PM EDT - Market closed

Inovio Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.070.220.8310.261.77
Revenue Growth (YoY)
--69.99%-73.83%-91.89%478.24%-76.05%
Gross Profit
-0.070.220.8310.261.77
Selling, General & Admin
31.5432.683747.5890.1953.75
Research & Development
52.1954.2175.6286.68187.65249.24
Other Operating Expenses
---10.51--
Total Operating Expenses
83.7286.89112.62144.77277.84302.99
Operating Income
-83.72-86.82-112.4-143.94-267.57-301.22
Interest Income
2.052.424.778.134.783.36
Interest Expense
---0.18-1.22-1.25-1.94
Other Non-Operating Income (Expense)
-3.26-0.540.561.91-15.77-3.87
Total Non-Operating Income (Expense)
-1.211.885.148.82-12.24-2.44
Pretax Income
-84.93-84.95-107.25-135.12-279.82-303.66
Net Income
-84.93-84.95-107.25-135.12-279.82-303.66
Net Income to Common
-84.93-84.95-107.25-135.12-279.82-303.66
Shares Outstanding (Basic)
564727222017
Shares Outstanding (Diluted)
564727222017
Shares Change (YoY)
79.22%72.63%22.49%11.51%14.27%34.62%
EPS (Basic)
-1.45-1.81-3.95-6.09-14.07-17.45
EPS (Diluted)
-1.45-1.81-3.95-6.09-14.07-17.45
Free Cash Flow
-83.57-88.92-104.56-124.69-217.19-216.94
Free Cash Flow Per Share
-1.50-1.90-3.85-5.62-10.92-12.47
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Margin
--132871.00%-51616.90%-17300.30%-2607.35%-16972.30%
Profit Margin
--130000.00%-49254.30%-16239.90%-2726.67%-17109.90%
FCF Margin
--136074.00%-48019.10%-14986.20%-2116.34%-12223.60%
EBITDA
-80.73-83.83-109.27-140.44-262.08-296.49
EBITDA Margin
--128297.00%-50179.50%-16879.20%-2553.80%-16705.80%
EBIT
-83.72-86.82-112.4-143.94-267.57-301.22
EBIT Margin
--132871.00%-51616.90%-17300.30%-2607.35%-16972.30%
SEC Filings: 10-K · 10-Q